- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股进入多头行情中，股价短线上涨概率较大。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有61家主力机构披露2025-12-31报告期持股数据，持仓量总计1.99亿股，占流通A股33.70%
- 波段诊断：
-
技术面诊股
诊断结果：6.1技术面打败了61%的股票
技术面评分前10的股票
近期的平均成本为5.30元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为5.30元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"5.30","date":1784102588,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，跑输行业平均水平。
[{"date":"2026.07.16","stock":"1.33","trade":"0.36","ind":"-1.97"},{"date":"2026.07.15","stock":"1.15","trade":"2.67","ind":"-0.97"},{"date":"2026.07.14","stock":"0.39","trade":"2.74","ind":"2.77"},{"date":"2026.07.13","stock":"-1.52","trade":"-1.36","ind":"-3.48"},{"date":"2026.07.10","stock":"5.20","trade":"3.33","ind":"-2.29"},{"date":"2026.07.09","stock":"-0.60","trade":"0.10","ind":"3.07"},{"date":"2026.07.08","stock":"0.20","trade":"-1.54","ind":"-1.87"},{"date":"2026.07.07","stock":"-1.18","trade":"-4.28","ind":"-1.24"},{"date":"2026.07.06","stock":"-2.12","trade":"1.41","ind":"-1.16"},{"date":"2026.07.03","stock":"-0.38","trade":"1.88","ind":"0.64"},{"date":"2026.07.02","stock":"-2.80","trade":"-0.24","ind":"-3.85"},{"date":"2026.07.01","stock":"0.56","trade":"4.33","ind":"-0.53"},{"date":"2026.06.30","stock":"-1.30","trade":"-0.54","ind":"2.48"},{"date":"2026.06.29","stock":"2.27","trade":"7.43","ind":"0.19"},{"date":"2026.06.26","stock":"-2.94","trade":"-3.87","ind":"-3.44"},{"date":"2026.06.25","stock":"-2.68","trade":"-1.00","ind":"1.82"},{"date":"2026.06.24","stock":"-0.89","trade":"-1.03","ind":"1.24"},{"date":"2026.06.23","stock":"4.25","trade":"2.96","ind":"-3.17"},{"date":"2026.06.22","stock":"-1.10","trade":"-0.76","ind":"2.13"},{"date":"2026.06.18","stock":"2.24","trade":"1.76","ind":"0.94"},{"date":"2026.06.17","stock":"3.08","trade":"-0.52","ind":"1.31"}]
东宝生物,深证成指,生物制品指数
压力支撑
该股压力位为5.25元，支撑位为5.13元。
[{"text":"\u538b\u529b\u4f4d","value":"5.25","date":1784131200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.13","date":1784131200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.2资金面打败了40%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：07月16日 20:30
| 机构今日流向(万元) | 1325.90 | 机构5日流向(万元) | 5506.55 |
| 机构10日流向(万元) | 3750.19 | 机构20日流向(万元) | 5375.27 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少1035.1万股，其中基金净增仓11家，主力净增仓19家，请投资者中长期谨慎为宜。
截止2025-12-31，共61家主力机构（基金56家，一般法人3家，社保基金1家，阳光私募1家），持仓量总计19873.47万股，占流通A股33.70%
其中，基金持仓与2025-06-30相比：
增仓：15家 ，增持 218.29万股
减仓：4家 ，减持 10.34万股
新出现在主力名单中：37家 ，持有307.9万股
从主力名单中消失：18家 ，原持有745.3万股
其中，基金持仓与2025-06-30相比：
增仓：15家 ，增持 218.29万股
减仓：4家 ，减持 10.34万股
新出现在主力名单中：37家 ，持有307.9万股
从主力名单中消失：18家 ，原持有745.3万股
消息面诊股
诊断结果：6.1消息面打败了78%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 东宝生物：胶原蛋白产品可作为电解铜箔生产专用工艺添
2026-07-07 - 东宝生物：公司胶原蛋白产品可作为电解铜箔生产专用工
2026-06-24 - 太强了！49个社保重仓股集体涨停，集中在4个方向，
2026-06-16 - 东宝生物：6月12日接受机构调研，东方财富证券股份
2026-06-13 - 东宝生物2025年净利5433.73万下降36.8
2026-06-12 - 东宝生物：胶原蛋白在电解铜箔领域已实现双增长
2026-06-03 - 东宝生物：5月27日召开业绩说明会，投资者参与
2026-05-27 - 东宝生物2025年全年每10股派0.12元 股权
2026-05-18 - 一季度长线资金持仓路径出炉 101家公司获社保基金
2026-05-07 - 股东追踪|BARCLAYS BANK PLC新进东
2026-04-23
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2026-03-30 |
| 利好 | 分红转增 | 10派0.12元(含税) | 2026-03-30 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-30 |
| 一般消息 | 募资投向 | 2026-03-29 | |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-22 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-29 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.7行业面打败了96%的股票
生物制品行业最新资金流向
近10日来该行业走势明显向上，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，跑赢大盘。
[{"date":"2026.07.16","price":"-1.97","value":"0.36"},{"date":"2026.07.15","price":"-0.97","value":"2.67"},{"date":"2026.07.14","price":"2.77","value":"2.74"},{"date":"2026.07.13","price":"-3.48","value":"-1.36"},{"date":"2026.07.10","price":"-2.29","value":"3.33"},{"date":"2026.07.09","price":"3.07","value":"0.10"},{"date":"2026.07.08","price":"-1.87","value":"-1.54"},{"date":"2026.07.07","price":"-1.24","value":"-4.28"},{"date":"2026.07.06","price":"-1.16","value":"1.41"},{"date":"2026.07.03","price":"0.64","value":"1.88"},{"date":"2026.07.02","price":"-3.85","value":"-0.24"},{"date":"2026.07.01","price":"-0.53","value":"4.33"},{"date":"2026.06.30","price":"2.48","value":"-0.54"},{"date":"2026.06.29","price":"0.19","value":"7.43"},{"date":"2026.06.26","price":"-3.44","value":"-3.87"},{"date":"2026.06.25","price":"1.82","value":"-1.00"},{"date":"2026.06.24","price":"1.24","value":"-1.03"},{"date":"2026.06.23","price":"-3.17","value":"2.96"},{"date":"2026.06.22","price":"2.13","value":"-0.76"},{"date":"2026.06.18","price":"0.94","value":"1.76"},{"date":"2026.06.17","price":"1.31","value":"-0.52"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 百普赛斯 | 39.36% | 11.78% | 6.5分 |
| 2 | 艾迪药业 | 34.58% | 21.13% | 6.9分 |
| 3 | 君实生物 | 32.83% | 8.44% | 6.6分 |
| 4 | 三生国健 | 32.78% | 0.00% | 5.5分 |
| 5 | 诺唯赞 | 30.89% | 5.39% | 6.2分 |
| 6 | 诺诚健华 | 30.87% | 0.38% | 5.8分 |
| 8 | 昊帆生物 | 28.81% | 6.43% | 6.2分 |
| 10 | 赛升药业 | 28.22% | 10.00% | 5.9分 |
| 12 | 义翘神州 | 26.34% | 9.43% | 6.5分 |
| 14 | 智翔金泰 | 24.22% | 8.11% | 5.8分 |
| 16 | 四环生物 | 23.25% | -3.01% | 5.6分 |
| 18 | 科兴制药 | 20.14% | 7.77% | 6.2分 |
| 20 | 双成药业 | 19.27% | 10.74% | 6.0分 |
| 22 | 康弘药业 | 18.98% | 7.72% | 6.3分 |
| 24 | 神州细胞 | 16.94% | 6.98% | 6.6分 |
| 26 | 通化东宝 | 16.42% | 7.79% | 6.9分 |
| 28 | - | 13.95% | 6.41% | 分 |
| 30 | 金迪克 | 11.90% | 8.21% | 4.9分 |
| 32 | 上海莱士 | 11.37% | 15.85% | 6.6分 |
| 34 | 博晖创新 | 11.11% | 13.38% | 5.9分 |
| 36 | 特宝生物 | 10.50% | 9.86% | 6.7分 |
| 38 | 优宁维 | 8.66% | 8.45% | 5.7分 |
| 40 | 康希诺 | 6.41% | 7.78% | 5.7分 |
| 42 | 康华生物 | 6.21% | 8.76% | 5.9分 |
| 44 | 成大生物 | 4.41% | 5.80% | 5.6分 |
| 46 | *ST未名 | 2.54% | 24.77% | 5.7分 |
| 48 | 东宝生物 | -0.37% | 6.60% | 5.8分 |
| 50 | - | -9.61% | 0.27% | 分 |
| 52 | 派林生物 | -11.07% | 12.20% | 6.4分 |
| 54 | 赛伦生物 | -18.94% | -2.32% | 4.2分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 21/71 ， 47/71。
[{"date":"2026-03-31","value":"1.14","vol":"-6.01"},{"date":"2025-12-31","value":"3.14","vol":"-12.99"},{"date":"2025-09-30","value":"2.80","vol":"-10.09"},{"date":"2025-06-30","value":"2.15","vol":"-0.66"},{"date":"2025-03-31","value":"1.10","vol":"-0.34"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.14 | 3.14 | 2.80 | 2.15 | 1.10 |
| 行业(%) | -6.01 | -12.99 | -10.09 | -0.66 | -0.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"24.29","vol":"61.43"},{"date":"2025-12-31","value":"23.36","vol":"66.53"},{"date":"2025-09-30","value":"24.53","vol":"67.71"},{"date":"2025-06-30","value":"25.44","vol":"66.67"},{"date":"2025-03-31","value":"25.06","vol":"38.38"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
24.29 | 23.36 | 24.53 | 25.44 | 25.06 |
| 行业(%) | 61.43 | 66.53 | 67.71 | 66.67 | 38.38 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 30/71 ， 25/71。
[{"date":"2026-03-31","value":"1.32","vol":"297.05"},{"date":"2025-12-31","value":"-15.78","vol":"39.85"},{"date":"2025-09-30","value":"-15.84","vol":"45.81"},{"date":"2025-06-30","value":"-16.93","vol":"6902.14"},{"date":"2025-03-31","value":"-22.23","vol":"6125.11"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
1.32 | -15.78 | -15.84 | -16.93 | -22.23 |
| 行业(%) | 297.05 | 39.85 | 45.81 | 6902.14 | 6125.11 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"3.41","vol":"74.22"},{"date":"2025-12-31","value":"-36.80","vol":"33.79"},{"date":"2025-09-30","value":"-26.89","vol":"45.67"},{"date":"2025-06-30","value":"-28.00","vol":"5.21"},{"date":"2025-03-31","value":"-26.64","vol":"-8.79"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
3.41 | -36.80 | -26.89 | -28.00 | -26.64 |
| 行业(%) | 74.22 | 33.79 | 45.67 | 5.21 | -8.79 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，两项指标的行业排名分别为 20/71 ， 12/71。
[{"date":"2026-03-31","value":"0.07","vol":"0.06"},{"date":"2025-12-31","value":"0.29","vol":"0.29"},{"date":"2025-09-30","value":"0.21","vol":"0.21"},{"date":"2025-06-30","value":"0.14","vol":"0.13"},{"date":"2025-03-31","value":"0.07","vol":"0.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.07 | 0.29 | 0.21 | 0.14 | 0.07 |
| 行业(次) | 0.06 | 0.29 | 0.21 | 0.13 | 0.06 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.35","vol":"0.29"},{"date":"2025-12-31","value":"1.51","vol":"1.29"},{"date":"2025-09-30","value":"1.04","vol":"0.90"},{"date":"2025-06-30","value":"0.74","vol":"0.55"},{"date":"2025-03-31","value":"0.39","vol":"0.25"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.35 | 1.51 | 1.04 | 0.74 | 0.39 |
| 行业(次) | 0.29 | 1.29 | 0.90 | 0.55 | 0.25 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"10.99","vol":"-78.67"},{"date":"2025-12-31","value":"20.94","vol":"12.85"},{"date":"2025-09-30","value":"6.79","vol":"0.21"},{"date":"2025-06-30","value":"48.52","vol":"-1377.65"},{"date":"2025-03-31","value":"-19.96","vol":"-2083.82"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 10.99 | 20.94 | 6.79 | 48.52 | -19.96 |
| 行业 | -78.67 | 12.85 | 0.21 | -1377.65 | -2083.82 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.81","vol":"1.74"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.60","vol":"1.55"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.81 | - | 0.60 | - |
| 行业 | 0.00 | 1.74 | 0.00 | 1.55 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 34/71 ， 28/71。
[{"date":"2026-03-31","value":"4.81","vol":"6.66"},{"date":"2025-12-31","value":"4.87","vol":"5.80"},{"date":"2025-09-30","value":"4.90","vol":"6.07"},{"date":"2025-06-30","value":"4.37","vol":"6.57"},{"date":"2025-03-31","value":"4.49","vol":"7.73"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
4.81 | 4.87 | 4.90 | 4.37 | 4.49 |
| 行业 | 6.66 | 5.80 | 6.07 | 6.57 | 7.73 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"3.00","vol":"5.14"},{"date":"2025-12-31","value":"3.12","vol":"4.43"},{"date":"2025-09-30","value":"3.07","vol":"4.89"},{"date":"2025-06-30","value":"2.87","vol":"5.24"},{"date":"2025-03-31","value":"3.06","vol":"6.33"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
3.00 | 3.12 | 3.07 | 2.87 | 3.06 |
| 行业 | 5.14 | 4.43 | 4.89 | 5.24 | 6.33 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，两项指标的行业排名分别为 14/71 ， 18/71。
[{"date":"2026-03-31","value":"32.29","vol":"28.78"},{"date":"2025-12-31","value":"32.42","vol":"28.75"},{"date":"2025-09-30","value":"32.50","vol":"28.02"},{"date":"2025-06-30","value":"33.79","vol":"26.19"},{"date":"2025-03-31","value":"33.71","vol":"26.65"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
32.29 | 32.42 | 32.50 | 33.79 | 33.71 |
| 行业(%) | 28.78 | 28.75 | 28.02 | 26.19 | 26.65 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.48","vol":"2.54"},{"date":"2025-12-31","value":"0.48","vol":"1.42"},{"date":"2025-09-30","value":"0.48","vol":"0.58"},{"date":"2025-06-30","value":"0.51","vol":"1.11"},{"date":"2025-03-31","value":"0.51","vol":"0.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.48 | 0.48 | 0.48 | 0.51 | 0.51 |
| 行业(%) | 2.54 | 1.42 | 0.58 | 1.11 | 0.80 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"1.09","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.20","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.86","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.54","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]